These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 758174)

  • 21. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid diagnosis of iron deficiency by measurement of free erythrocyte porphyrins and hemoglobin: the FEP/hemoglobin ratio.
    Piomelli S; Brickman A; Carlos E
    Pediatrics; 1976 Jan; 57(1):136-41. PubMed ID: 1246489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
    Rachmilewitz EA; Weizer-Stern O; Adamsky K; Amariglio N; Rechavi G; Breda L; Rivella S; Cabantchik ZI
    Ann N Y Acad Sci; 2005; 1054():118-23. PubMed ID: 16339657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron balance and the management of iron overload in beta-thalassemia intermedia.
    Pippard MJ; Weatherall DJ
    Birth Defects Orig Artic Ser; 1988; 23(5B):29-33. PubMed ID: 3390555
    [No Abstract]   [Full Text] [Related]  

  • 26. Reevaluation of iron absorption and serum ferritin in beta-thalassemia intermedia.
    Gümrük F; Gürgey A; Duru F; Altay C
    Pediatr Hematol Oncol; 1992; 9(4):359-63. PubMed ID: 1467169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of small erythrocytes.
    Okuno T; Chou A
    Am J Clin Pathol; 1975 Jul; 64(1):48-52. PubMed ID: 1155374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of iron deficiency among schoolchildren of different socio-economic status in urban Turkey.
    Keskin Y; Moschonis G; Dimitriou M; Sur H; Kocaoglu B; Hayran O; Manios Y
    Eur J Clin Nutr; 2005 Jan; 59(1):64-71. PubMed ID: 15280908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron absorption and loading in beta-thalassaemia intermedia.
    Pippard MJ; Callender ST; Warner GT; Weatherall DJ
    Lancet; 1979 Oct; 2(8147):819-21. PubMed ID: 90918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Absorption and metabolic efficiency of iron in nickel deficiency].
    Schnegg A; Kirchgessner M
    Int J Vitam Nutr Res; 1976; 46(1):96-9. PubMed ID: 1262140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia.
    Gorodetsky R; Goldfarb A; Dagan I; Rachmilewitz EA
    J Lab Clin Med; 1985 Jan; 105(1):44-51. PubMed ID: 3968464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Food iron absorption in man. Applications of the two-pool extrinsic tag method to measure heme and nonheme iron absorption from the whole diet.
    Björn-Rasmussen E; Hallberg L; Isaksson B; Arvidsson B
    J Clin Invest; 1974 Jan; 53(1):247-55. PubMed ID: 4808639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
    Taher A; El Rassi F; Isma'eel H; Koussa S; Inati A; Cappellini MD
    Haematologica; 2008 Oct; 93(10):1584-6. PubMed ID: 18728025
    [No Abstract]   [Full Text] [Related]  

  • 34. One for tea, not two.
    Davis SG; Murray JA
    Clin Lab Haematol; 1996 Dec; 18(4):289-90. PubMed ID: 9054705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma chitotriosidase activity in patients with beta-thalassemia.
    Barone R; Di Gregorio F; Romeo MA; Schilirò G; Pavone L
    Blood Cells Mol Dis; 1999 Feb; 25(1):1-8. PubMed ID: 10349508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
    N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron chelation in thalassemia: mechanism of desferrioxamine action.
    Hershko C; Rachmilewitz EA
    Isr J Med Sci; 1978 Nov; 14(11):1111-5. PubMed ID: 750535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
    N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of rooibos tea on iron absorption].
    Hesseling PB; Klopper JF; van Heerden PD
    S Afr Med J; 1979 Apr; 55(16):631-2. PubMed ID: 462276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron absorption in patients with beta-thalassaemia/haemoglobin E disease and the effect of splenectomy.
    Vatanavicharn S; Anuwatanakulchai M; Tuntawiroon M; Suwanik R; Wasi P
    Acta Haematol; 1983; 69(6):414-6. PubMed ID: 6190341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.